111 related articles for article (PubMed ID: 32898439)
21. Evaluation of 99mTc-peptide-ZHER2:342 Affibody® molecule for in vivo molecular imaging.
Zhang JM; Zhao XM; Wang SJ; Ren XC; Wang N; Han JY; Jia LZ
Br J Radiol; 2014 Jan; 87(1033):20130484. PubMed ID: 24273251
[TBL] [Abstract][Full Text] [Related]
22.
Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
J Biomed Sci; 2018 Feb; 25(1):17. PubMed ID: 29455647
[TBL] [Abstract][Full Text] [Related]
23. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of
Maleki F; Masteri Farahani A; Sadeghzadeh N; Mardanshahi A; Abediankenari S
Chem Biol Drug Des; 2020 Nov; 96(5):1223-1231. PubMed ID: 32426902
[TBL] [Abstract][Full Text] [Related]
25.
Sadeghi H; Rahmanian N; Amiri FT; Amirfakhrian H; Abedi SM; Hosseinimehr SJ
Iran J Basic Med Sci; 2018 Jan; 21(1):77-82. PubMed ID: 29372040
[TBL] [Abstract][Full Text] [Related]
26. Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with
Larkina M; Plotnikov E; Bezverkhniaia E; Shabanova Y; Tretyakova M; Yuldasheva F; Zelchan R; Schulga A; Konovalova E; Vorobyeva A; Garousi J; Gräslund T; Belousov M; Tolmachev V; Deyev S
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362226
[TBL] [Abstract][Full Text] [Related]
27. Preparation and
Okarvi SM; Aljammaz I
Anticancer Res; 2018 May; 38(5):2823-2830. PubMed ID: 29715105
[TBL] [Abstract][Full Text] [Related]
28. MicroPET imaging of tumor angiogenesis and monitoring on antiangiogenic therapy with an (18)F labeled RGD-based probe in SKOV-3 xenograft-bearing mice.
Yang G; Nie P; Kong Y; Sun H; Hou G; Han J
Tumour Biol; 2015 May; 36(5):3285-91. PubMed ID: 25501513
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.
Zhou Y; Kim YS; Lu X; Liu S
Bioconjug Chem; 2012 Mar; 23(3):586-95. PubMed ID: 22369387
[TBL] [Abstract][Full Text] [Related]
30. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
31. Targeting and imaging of HER2 overexpression tumor with a new peptide-based
Biabani Ardakani J; Akhlaghi M; Nikkholgh B; Hosseinimehr SJ
Bioorg Chem; 2021 Jan; 106():104474. PubMed ID: 33246602
[TBL] [Abstract][Full Text] [Related]
32. A HER2-targeted RNA aptamer molecule labeled with 99mTc for single-photon imaging in malignant tumors.
Varmira K; Hosseinimehr SJ; Noaparast Z; Abedi SM
Nucl Med Biol; 2013 Nov; 40(8):980-6. PubMed ID: 23953624
[TBL] [Abstract][Full Text] [Related]
33. Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake.
Ekblad T; Tran T; Orlova A; Widström C; Feldwisch J; Abrahmsén L; Wennborg A; Karlström AE; Tolmachev V
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2245-55. PubMed ID: 18594815
[TBL] [Abstract][Full Text] [Related]
34. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
35. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.
Liu Y; Lan X; Wu T; Lang J; Jin X; Sun X; Wen Q; An R
Nucl Med Biol; 2014 Jul; 41(6):450-6. PubMed ID: 24768147
[TBL] [Abstract][Full Text] [Related]
36. Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides.
Yang Y; Ji S; Liu S
Bioconjug Chem; 2014 Sep; 25(9):1720-9. PubMed ID: 25144854
[TBL] [Abstract][Full Text] [Related]
37. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
Fu P; Shen B; Zhao C; Tian G
J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
[TBL] [Abstract][Full Text] [Related]
38. Imaging of therapy-induced apoptosis using (99m)Tc-HYNIC-annexin V in thymoma tumor-bearing mice.
Wong E; Kumar V; Howman-Giles RB; Vanderheyden JL
Cancer Biother Radiopharm; 2008 Dec; 23(6):715-26. PubMed ID: 19111046
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive evaluation of HABP1 expression with
Duan C; Gao Y; Luan S; Guo S; Cao X; Xu P; Fu P; Zhao C
Int J Radiat Biol; 2021; 97(11):1569-1577. PubMed ID: 34402389
[TBL] [Abstract][Full Text] [Related]
40. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]